Blueblood Ventures appoints Singh as independent director, opens Kolkata branch

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Chandrashekhar Singh appointed as Non-Executive Independent Director effective October 9, 2026
  • New Kolkata branch office approved with monthly rent of ₹20,000 from a related party
  • M/s. Mahesh Sharma & Associates appointed as Internal Auditor for FY27-FY31 at ₹25,000 per annum
  • Board approved debt assignment transactions and potential share sale of SJM Investments
powered bylight_fuzz_icon
53091216

*this image is generated using AI for illustrative purposes only.

Blueblood Ventures Limited appointed Chandrashekhar Singh as an Additional Director in the category of Non-Executive Independent Director on October 9, 2026. The company also approved the establishment of a branch office in Kolkata and the appointment of a new internal auditor.

Singh, who holds DIN 05131693, has furnished a declaration confirming he meets the criteria of independence under Section 149(6) of the Companies Act, 2013. He holds no shareholding in the company and is not related to any existing directors. His appointment is subject to shareholder approval at the ensuing Annual General Meeting for a term of five consecutive years.

Branch office expansion and related-party transaction

The Board approved, in principle, the opening of a branch office at Standard Chartered Bank Building, 19, N.S. Road, Kolkata. The premises are owned by Dill Developers Private Limited, which is linked to Managing Director Suresh Bohra. The monthly rent is set at ₹20,000 effective October 1, 2026. The Board directed compliance with Sections 177 and 188 of the Companies Act, 2013, regarding this related-party transaction.

The new office aims to facilitate business operations, development, and coordination in Eastern India. The Company Secretary is authorized to execute necessary documents for this expansion.

Governance and audit updates

M/s. Mahesh Sharma & Associates, Chartered Accountants (Firm Registration No. 014330N), was appointed as the Internal Auditor for financial years FY27 to FY31. The professional fee is fixed at ₹25,000 per annum plus applicable taxes. The firm brings over 30 years of experience in taxation, auditing, and statutory compliances.

Additionally, the Board approved a Debt Assignment Transaction involving Mr. Anuranjan Jha, Pradeep Kumar, and Amit Kumar Kushwaha. It also authorized potential Share Purchase/Sale transactions of SJM Investments (Delhi) Private Limited.

What the Numbers Show

The appointment of a new internal auditor at a fee of ₹25,000 per annum coincides with the establishment of a physical presence in Kolkata at a monthly rent of ₹20,000. This suggests a modest operational scale where governance costs remain low relative to fixed infrastructure expenses. The related-party nature of the Kolkata lease, involving the Managing Director’s entity, requires strict adherence to SEBI Listing Regulations to ensure arm's length pricing transparency.

How will the ₹25,000 annual internal audit fee impact the perceived robustness of Blueblood Ventures' governance framework among institutional investors?

What specific market opportunities in Eastern India is the Kolkata branch office targeting to justify the operational expansion?

Will the related-party lease agreement with Dill Developers Private Limited face scrutiny regarding arm's length pricing compliance under SEBI regulations?

like16
dislike

Blueblood Ventures adopts FY26 results, reappoints Suresh Bohra

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Blueblood Ventures adopted standalone FY26 audited financial statements
  • Suresh Bohra reappointed as director retiring by rotation
  • Both resolutions passed unanimously with 17,35,080 votes in favour
  • Only 12 of 62 registered shareholders attended the AGM
powered bylight_fuzz_icon
52316955

*this image is generated using AI for illustrative purposes only.

Blueblood Ventures Limited adopted its standalone audited financial statements for the fiscal year ended March 31, 2026, during its 19th Annual General Meeting held on September 30, 2026. The meeting also confirmed the reappointment of Chairman Suresh Bohra as a director retiring by rotation.

The AGM took place at the company's registered office in New Delhi. Key resolutions were passed unanimously through a show of hands, reflecting strong shareholder consensus on both financial adoption and board continuity.

Voting outcomes and attendance

The company disclosed detailed voting patterns for the two ordinary resolutions passed. A total of 17,35,080 shares were polled for each item, with zero votes cast against either resolution. Promoter and promoter group members held 15,94,080 shares, while public non-institutional shareholders held 141,000 shares. No institutional public shareholders participated in the voting process.

Resolution Shares Polled Votes in Favour Votes Against Result
Adoption of FY26 financials 17,35,080 17,35,080 0 Passed
Reappointment of Suresh Bohra 17,35,080 17,35,080 0 Passed

Shareholder participation details

Attendance records indicate that out of 62 total shareholders on the record date, only 12 individuals were present either in person or through proxy. This comprised seven members from the promoter and promoter group and five public shareholders. No shareholders attended the meeting via video conferencing.

The low turnout relative to the total shareholder count highlights the concentrated nature of ownership and participation in this micro-cap entity. The absence of e-voting or postal ballot mechanisms for these routine items suggests they were not deemed contentious by the board or regulators under SEBI (LODR) Regulations, 2015.

How might the absence of institutional shareholder participation impact Blueblood Ventures' future access to capital and valuation multiples?

Will the continued reliance on promoter-led governance without independent institutional oversight trigger increased regulatory scrutiny from SEBI in upcoming quarters?

What strategic initiatives are planned to improve public float and retail investor engagement given the current low attendance and concentrated ownership structure?

like16
dislike

More News on Blueblood Ventures Limited